Skip to main content

Table 1 Clinical Characteristics of the Patients (A total of 4 patients with CD were included between June 2020 and September 2020

From: An alternative splicing signature in human Crohn’s disease

  Patient1 Patient2 Patient3 Patient4
Age (years) 16 22 30 23
Gender Male Female Female Male
Course of disease (years) 1.5 0.5 4 3
Age at diagnosis 15 22 29 21
Disease phenotype B3 B1 B1p B2p
Disease location L3 L3 L3 L2
CDAI 160 170 410 240
Medication Anti-TNF-a therapy 5-ASA and Anti-TNF-a therapy Anti-TNF-a therapy Anti-TNF-a therapy and corticosteroids
  1. The clinical characteristics of all patients are shown in Table 1. There were no significant differences with regard to age and sex between the experimental and control groups (P > 0.05).)
  2. Locations: L1 = terminal ileum; L2 = colon; L3 = ileocolon. Behaviors: B1 = nonstricturing; B2 = stricturing, B3 = penetrating; P = perianal disease
  3. ASA, Aminosalicylic acid